Profil bibliographique

Oskar Eklund

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

36Publications signalées

95Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Genetic and Kidney Cyst DiseasesRenal Diseases and GlomerulopathiesChronic Obstructive Pulmonary Disease (COPD) ResearchGallbladder and Bile Duct DisordersLiver Diseases and Immunity

Publications récentes

Accès ouvert 2026 articleOpenAlex

Real-world patterns of healthcare use, costs, and survival in diffuse large B-cell lymphoma: a nationwide Swedish register study

Eva Herweijer, Kaisa Miikkulainen, Oskar Eklund, Brett Doble et autres

0 citationsThe European Journal of Health Economics

2025 conference-abstractOpenAlex

EE524 Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost

Dilip Makhija, Marvin Rock, Chong Kim, Caroline Burk et autres

0 citationsValue in Health

2025 conference-abstractOpenAlex

MSR108 Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis

David Jones, Robert G. Gish, Gideon M. Hirschfield, Cynthia Levy et autres

0 citationsValue in Health

2025 conference-abstractOpenAlex

CO156 Investigating Composite Response Definitions Based on Key Surrogate Markers for Predicting Clinical Outcomes in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis

Dilip Makhija, Marvin Rock, Chong Kim, Michael F. Hein et autres

0 citationsValue in Health

2025 reviewOpenAlex

PCR110 Health Utility Values in Adults With Primary Biliary Cholangitis: A Global Systematic Literature Review

Dilip Makhija, Marvin Rock, Chong Kim, Caroline Burk et autres

0 citationsValue in Health

Accès ouvert 2025 articleOpenAlex

Guided smoothing and control for diffusion processes

Oskar Eklund, Annika Lang, Moritz Schauer

0 citationsStochastic Processes and their Applications

Accès ouvert 2025 articleOpenAlex

Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL

S. Harper, Daniela Afonso, Karina Watts, Brett Doble et autres

0 citationsPharmacoEconomics

2025 reviewOpenAlex

CO170 Exploring the Relationship Between Surrogate Endpoints and Clinical Outcomes in Primary Biliary Cholangitis: A Systematic Literature Review and Meta-Analysis

Dilip Makhija, Marvin Rock, Chong Kim, Michael F. Hein et autres

0 citationsValue in Health

Accès ouvert 2025 preprintOpenAlex

Guided smoothing and control for diffusion processes

Oskar Eklund, Annika Lang, Moritz Schauer

0 citationsarXiv (Cornell University)

2023 conference-abstractOpenAlex

EE536 Cost-Effectiveness of Axicabtagene Ciloleucel (axi-cel) Vs Standard of Care for Adult Patients with Relapsed or Refractory Follicular Lymphoma as 4TH or Later Line Treatment in Sweden

Oskar Eklund, Viktor Hedlof Kanje, Brett Doble, K. Cervin

1 citationValue in Health

Accès ouvert 2023 articleOpenAlex

Axicabtagene ciloleucel compared to standard of care in Swedish patients with large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial

Anne Sofie Ledgaard Loftager, Anne Danø, Oskar Eklund, Sachin Vadgama et autres

16 citationsJournal of Medical Economics

Accès ouvert 2023 datasetOpenAlex

Axicabtagene ciloleucel compared to standard of care in Swedish patients with large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial

Anne Sofie Ledgaard Loftager, Anne Danø, Oskar Eklund, Sachin Vadgama et autres

0 citationsFigshare

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.